Transfusion-transmitted cytomegalovirus: behaviour of cell-free virus during blood component processing. A study on the safety of labile blood components in Switzerland

BACKGROUND: Nowadays, most blood products are leukocyte-reduced. After this procedure, the residual risk for transfusion transmitted cytomegalovirus (TT-CMV) is mostly attributed to cell-free viruses in the plasma of blood donors following primary infection or viral reactivation. Here, objectives ar...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Blood Transfus
Hlavní autoři: Voruz, Sophie, Gowland, Peter, Eyer, Claudia, Widmer, Nadja, Abonnenc, Mélanie, Prudent, Michel, Masouridi-Levrat, Stavroula, Duchosal, Michel A., Niederhauser, Christoph
Médium: Artigo
Jazyk:Inglês
Vydáno: Edizioni SIMTI - SIMTI Servizi Srl 2020
Témata:
Blood Components and Regenerative Medicine
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7605881/
https://ncbi.nlm.nih.gov/pubmed/32203012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2450/2020.0241-19
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky